plumbagin has been researched along with Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Janathia, B; Thakor, N | 1 |
| Ahmad, I; Alam, SSM; Hoque, M; Tabrez, S; Zughaibi, TA | 1 |
| Roy, A | 1 |
| Chen, L; Guo, Q; Kang, W; Yang, B; Yin, Z; Zhang, J; Zhang, W | 1 |
| Cai, Y; Chen, M; He, C; Li, H; Liu, Y | 1 |
| Biswal, BK; Panda, M; Tripathi, SK | 1 |
| Binoy, A; Bose, C; Katiyar, N; Mishra, N; Nair, BG; Nedungadi, D; Shankarappa, SA | 1 |
| Cai, W; Liu, X; Niu, M; Xu, K; Xu, X; Yu, R; Zeng, L; Zhou, X | 1 |
| Tuorkey, MJ | 1 |
| Ahmad, A; Azmi, AS; Hadi, SM; Hanif, S; Kumar, KS; Mohammad, RM; Nazeem, S | 1 |
| Chen, Y; Dong, Y; He, L; Lai, L; Lin, Q; Liu, J; Liu, M; Lu, B; Yi, Z; Zhai, D; Zhang, J | 1 |
| Bao, JL; Chen, XP; Huang, MQ; Lu, JJ; Wang, YT; Wu, GS; Xu, WS | 1 |
7 review(s) available for plumbagin and Neoplasms
| Article | Year |
|---|---|
Plumbagin: A Potential Candidate for Future Research and Development.
Topics: Animals; Humans; Naphthoquinones; Neoplasms; Plumbaginaceae; Research | 2022 |
Plumbagin: A Potential Anti-cancer Compound.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Humans; Naphthoquinones; Neoplasms; NF-kappa B; Plumbaginaceae; Signal Transduction | 2021 |
Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; DNA Breaks, Double-Stranded; DNA Damage; Drug Screening Assays, Antitumor; Glutathione; Humans; Inhibitory Concentration 50; Liposomes; Mice; Mice, Inbred C57BL; Naphthoquinones; Neoplasm Metastasis; Neoplasms; Oxidants; Oxygen; Plant Extracts; Plants, Medicinal; Proteasome Inhibitors; Reactive Oxygen Species; Superoxides | 2020 |
Anticancer Properties and Pharmaceutical Applications of Plumbagin: A Review.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Droseraceae; Ebenaceae; Genes, ras; Humans; In Vitro Techniques; Mice; Naphthoquinones; Neoplasms; Phosphatidylinositol 3-Kinase; Phytotherapy; Plumbaginaceae; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2017 |
Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Humans; Male; Naphthoquinones; Neoplasms; Reactive Oxygen Species; Signal Transduction | 2019 |
Cancer Therapy with Phytochemicals: Present and Future Perspectives.
Topics: Acetophenones; Antineoplastic Agents, Phytogenic; Benzopyrans; Benzylisoquinolines; Catechols; Heterocyclic Compounds, 4 or More Rings; Humans; Isothiocyanates; Naphthoquinones; Neoplasms; Phytotherapy; Plant Extracts; Signal Transduction; Sulfoxides | 2015 |
Quinones derived from plant secondary metabolites as anti-cancer agents.
Topics: Anthraquinones; Antineoplastic Agents, Phytogenic; Benzoquinones; Cell Line, Tumor; Cell Survival; Humans; Naphthoquinones; Neoplasms; Plant Extracts | 2013 |
5 other study(ies) available for plumbagin and Neoplasms
| Article | Year |
|---|---|
Curcumin and Plumbagin Synergistically Target the PI3K/Akt/mTOR Pathway: A Prospective Role in Cancer Treatment.
Topics: Curcumin; Humans; Molecular Docking Simulation; Neoplasms; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2023 |
Plumbagin induces paraptosis in cancer cells by disrupting the sulfhydryl homeostasis and proteasomal function.
Topics: Cell Death; Cell Line; Cell Line, Tumor; Endoplasmic Reticulum Stress; Homeostasis; Humans; Membrane Potential, Mitochondrial; Naphthoquinones; Neoplasms; Proteasome Inhibitors; Sulfhydryl Compounds; Vacuoles | 2019 |
CRM1 is a direct cellular target of the natural anti-cancer agent plumbagin.
Topics: Cell Line, Tumor; Cell Nucleus; Drug Design; Exportin 1 Protein; Humans; Karyopherins; Molecular Targeted Therapy; Naphthoquinones; Neoplasms; Nuclear Proteins; Phytotherapy; Plumbaginaceae; Protein Transport; Receptors, Cytoplasmic and Nuclear; Tumor Suppressor Proteins | 2014 |
Plumbagin induces cell death through a copper-redox cycle mechanism in human cancer cells.
Topics: Cell Death; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Shape; Comet Assay; Copper; Cytoprotection; Free Radical Scavengers; Humans; Naphthoquinones; Neoplasms; Oxidation-Reduction; Phenanthrolines; Skin Neoplasms | 2009 |
Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2.
Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chickens; Chorioallantoic Membrane; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred C57BL; Mice, Nude; Naphthoquinones; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; ras Proteins; Signal Transduction; Tumor Burden; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2012 |